EIF2AK2 and breast carcinoma: As shown in Fig. 1C, the levels of PKR expression/phosphorylation were much lower in more aggressive breast cancer cell lines (MDA-MB231, BT474 and SKBR3) than in the less aggressive line (MCF-7).